Fenfluramine Add-On Therapy of Dravet Syndrome
Abstract
Researchers at Antwerp University Hospital and University of Leuven, Belgium report 12 patients, 7 female and 5 male, age range 3-35 years, with a genetically proven diagnosis of Dravet syndrome who received fenfluramine (mean dose 0.34 (0.12-0.90) mg/kg/day) as add-on therapy.
DOI: https://doi.org/10.15844/pedneurbriefs-26-8-7 | Journal eISSN: 2166-6482
Language: English
Page range: 61 - 62
Published on: Aug 1, 2012
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2012 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.